METHYLPREDNISOLONE SODIUM SUCCINATE

METHYLPREDNISOLONE SODIUM SUCCINATE was reported 46926 times

METHYLPREDNISOLONE SODIUM SUCCINATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 151 0.4983
1 HEPATIC ENZYME 73 0.4899
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 267 0.3997
3 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 207 0.3690
4 BLOOD PRESSURE DIASTOLIC ABNORMAL 921 0.3617
5 BLOOD PRESSURE SYSTOLIC ABNORMAL 828 0.3347
6 HYPOCHOLESTEROLAEMIA 114 0.3229
7 SWOLLEN JOINT COUNT 78 0.3120
8 LUPUS VULGARIS 382 0.3032
9 NEUROLOGIC NEGLECT SYNDROME 159 0.2860
10 HUMAN BOCAVIRUS INFECTION 47 0.2487
11 RETINITIS 426 0.2464
12 DISLOCATION OF VERTEBRA 544 0.2383
13 SERONEGATIVE ARTHRITIS 273 0.2382
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 477 0.2300
15 RHEUMATIC FEVER 1012 0.2268
16 FACET JOINT SYNDROME 729 0.2237
17 DEEP VEIN THROMBOSIS POSTOPERATIVE 419 0.2092
18 SWOLLEN JOINT COUNT INCREASED 630 0.1974
19 CAROTID ARTERY THROMBOSIS 158 0.1861
20 X-RAY ABNORMAL 333 0.1860
21 C-REACTIVE PROTEIN 163 0.1758
22 PERIPHERAL VENOUS DISEASE 663 0.1622
23 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1155 0.1610
24 OVERLAP SYNDROME 111 0.1586
25 DUODENAL ULCER PERFORATION 1153 0.1549
26 RHEUMATOID FACTOR POSITIVE 829 0.1434
27 HELICOBACTER INFECTION 1245 0.1210
28 TEMPERATURE REGULATION DISORDER 269 0.1206
29 HYPERCHOLESTEROLAEMIA 1150 0.1190
30 ADJUSTMENT DISORDER 154 0.1185
31 PEMPHIGUS 1481 0.1183
32 MUSCLE INJURY 979 0.1180
33 CRYSTAL URINE PRESENT 63 0.1133
34 URINARY SEDIMENT PRESENT 72 0.1118
35 URINE LEUKOCYTE ESTERASE POSITIVE 77 0.1100
36 ONYCHOMADESIS 446 0.1062
37 FOLLICULITIS 1102 0.1050
38 BONE EROSION 371 0.1048
39 DEATH NEONATAL 145 0.1042
40 HAND DEFORMITY 1360 0.1036
41 FEMALE GENITAL TRACT FISTULA 172 0.1006
42 BREAST CANCER STAGE III 622 0.0959
43 NEUTROPHIL PERCENTAGE INCREASED 118 0.0935
44 STEROID DIABETES 138 0.0919
45 C-REACTIVE PROTEIN ABNORMAL 584 0.0910
46 LYMPHOCYTE PERCENTAGE DECREASED 119 0.0885
47 WOUND INFECTION 967 0.0882
48 BURSITIS 1064 0.0876
49 ONYCHOMYCOSIS 383 0.0872
50 GRIP STRENGTH DECREASED 765 0.0868
51 MONOCYTE PERCENTAGE INCREASED 61 0.0860
52 PERICARDITIS 1439 0.0856
53 JOINT RANGE OF MOTION DECREASED 1138 0.0848
54 BLEPHAROSPASM 534 0.0847
55 LIP DRY 750 0.0825
56 MYCOBACTERIUM CHELONAE INFECTION 60 0.0812
57 RED BLOOD CELLS URINE POSITIVE 78 0.0807
58 SYNOVITIS 1359 0.0753
59 CYTOMEGALOVIRUS TEST POSITIVE 133 0.0746
60 BLOOD PRESSURE DIASTOLIC DECREASED 537 0.0727
61 BLOOD PRESSURE SYSTOLIC INCREASED 1416 0.0725
62 BLOOD PRESSURE DIASTOLIC INCREASED 331 0.0716
63 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 465 0.0715
64 PORPHYRIA ACUTE 95 0.0662
65 PUSTULAR PSORIASIS 226 0.0657
66 FINGER DEFORMITY 303 0.0625
67 GLOSSODYNIA 1390 0.0620
68 RADICULOPATHY 163 0.0618
69 SECONDARY IMMUNODEFICIENCY 75 0.0617
70 PERSONALITY DISORDER 160 0.0610
71 PROCTITIS 171 0.0610
72 INFUSION RELATED REACTION 4031 0.0608
73 WHITE BLOOD CELLS URINE POSITIVE 114 0.0605
74 NAIL DISORDER 512 0.0585
75 PHARYNGEAL PARAESTHESIA 92 0.0579
76 GRANULOMATOSIS WITH POLYANGIITIS 67 0.0555
77 WALKING AID USER 362 0.0548
78 IRRITABLE BOWEL SYNDROME 1161 0.0541
79 FIBROMYALGIA 1304 0.0536
80 WOUND 1462 0.0523
81 LIVER INJURY 1269 0.0516
82 LIVE BIRTH 426 0.0509
83 FOOD ALLERGY 392 0.0507
84 SUSPECTED OFF LABEL USE 226 0.0500
85 RED BLOOD CELL SEDIMENTATION RATE INCREASED 551 0.0497
86 BLOOD PRESSURE FLUCTUATION 1190 0.0495
87 AUTOIMMUNE DISORDER 469 0.0481
88 COELIAC DISEASE 464 0.0473
89 EXOSTOSIS 428 0.0468
90 RASH VESICULAR 226 0.0467
91 SPONDYLITIS 166 0.0456
92 TYPE 2 DIABETES MELLITUS 1522 0.0452
93 CHRONIC SINUSITIS 166 0.0442
94 BREAST CANCER STAGE II 365 0.0438
95 SYSTEMIC LUPUS ERYTHEMATOSUS 1541 0.0434
96 CYTOMEGALOVIRUS VIRAEMIA 192 0.0431
97 FOETAL DEATH 222 0.0428
98 PRESCRIBED OVERDOSE 818 0.0422
99 CULTURE URINE POSITIVE 59 0.0420
100 OBESITY 665 0.0417
101 BACTERIAL TEST POSITIVE 93 0.0417
102 ENTEROBACTER INFECTION 70 0.0416
103 LUPUS-LIKE SYNDROME 372 0.0410
104 INFUSION SITE REACTION 121 0.0405
105 CUSHINGOID 127 0.0395
106 JOINT DISLOCATION 417 0.0394
107 GRAFT VERSUS HOST DISEASE IN SKIN 85 0.0385
108 C-REACTIVE PROTEIN INCREASED 1369 0.0376
109 CONTRAINDICATED PRODUCT ADMINISTERED 1136 0.0375
110 URINE ANALYSIS ABNORMAL 112 0.0374
111 PRODUCT LABEL CONFUSION 218 0.0374
112 EAR PRURITUS 129 0.0368
113 PULMONARY FIBROSIS 704 0.0367
114 COMPLICATIONS OF TRANSPLANTED KIDNEY 83 0.0366
115 BACK INJURY 396 0.0364
116 RED CELL DISTRIBUTION WIDTH INCREASED 150 0.0361
117 HUMAN HERPESVIRUS 6 INFECTION 68 0.0359
118 IMPAIRED HEALING 1180 0.0359
119 SCIATICA 563 0.0353
120 PSEUDOMONAL SEPSIS 61 0.0348
121 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 95 0.0343
122 GANGRENE 206 0.0342
123 PNEUMATOSIS INTESTINALIS 96 0.0336
124 IMMUNODEFICIENCY 501 0.0336
125 DRUG TOLERANCE DECREASED 92 0.0327
126 MEAN CELL HAEMOGLOBIN INCREASED 54 0.0326
127 BODY TEMPERATURE DECREASED 321 0.0326
128 FOOT DEFORMITY 357 0.0322
129 PSORIATIC ARTHROPATHY 1300 0.0320
130 CONGENITAL ANOMALY 245 0.0316
131 SCLERITIS 50 0.0312
132 KIDNEY TRANSPLANT REJECTION 149 0.0310
133 LUPUS NEPHRITIS 58 0.0310
134 LOWER RESPIRATORY TRACT CONGESTION 52 0.0306
135 OXYGEN SATURATION DECREASED 1658 0.0295
136 BLOOD CHOLESTEROL INCREASED 1374 0.0294
137 HIP ARTHROPLASTY 451 0.0294
138 URINE ABNORMALITY 133 0.0292
139 ARTERIAL OCCLUSIVE DISEASE 228 0.0290
140 MYOSITIS 259 0.0288
141 BRONCHOPULMONARY ASPERGILLOSIS 221 0.0285
142 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 75 0.0282
143 OSTEOARTHRITIS 1190 0.0280
144 HEART RATE DECREASED 984 0.0280
145 HEPATIC ENZYME INCREASED 1887 0.0277
146 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 46 0.0276
147 LYMPHOCYTE COUNT DECREASED 487 0.0275
148 LOWER LIMB FRACTURE 518 0.0269
149 SENSORY LOSS 215 0.0267
150 GAIT INABILITY 891 0.0266
151 GENERAL SYMPTOM 199 0.0265
152 LIVER FUNCTION TEST INCREASED 565 0.0263
153 PRESCRIBED UNDERDOSE 518 0.0259
154 STAPHYLOCOCCAL SEPSIS 128 0.0259
155 CYTOMEGALOVIRUS INFECTION 429 0.0258
156 ARTHROPATHY 1432 0.0257
157 ENTEROCOCCAL INFECTION 123 0.0254
158 HEMIPLEGIA 211 0.0253
159 MUSCLE SPASTICITY 311 0.0253
160 TASTE DISORDER 512 0.0252
161 POOR VENOUS ACCESS 260 0.0251
162 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 56 0.0250
163 LOWER RESPIRATORY TRACT INFECTION 1131 0.0248
164 ORAL PRURITUS 57 0.0248
165 HYPOPROTEINAEMIA 47 0.0247
166 PNEUMONIA CYTOMEGALOVIRAL 48 0.0247
167 BLOOD PRESSURE SYSTOLIC DECREASED 112 0.0246
168 DISORGANISED SPEECH 45 0.0244
169 INTENTIONAL PRODUCT USE ISSUE 2132 0.0243
170 NIGHT SWEATS 784 0.0243
171 SYSTEMIC CANDIDA 61 0.0243
172 PROTEIN URINE PRESENT 121 0.0242
173 WHEEZING 1424 0.0240
174 HISTIOCYTOSIS HAEMATOPHAGIC 71 0.0239
175 ASPERGILLUS INFECTION 156 0.0237
176 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 90 0.0235
177 SPINAL FUSION SURGERY 95 0.0234
178 PNEUMOCYSTIS JIROVECI PNEUMONIA 52 0.0233
179 RESPIRATORY RATE INCREASED 207 0.0233
180 CYTOMEGALOVIRUS CHORIORETINITIS 45 0.0231
181 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 54 0.0230
182 LUNG DISORDER 1111 0.0226
183 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 48 0.0225
184 SERUM SICKNESS 62 0.0222
185 BLISTER 1248 0.0222
186 RHEUMATOID ARTHRITIS 2511 0.0221
187 CYTOLYTIC HEPATITIS 73 0.0220
188 HEPATIC CIRRHOSIS 413 0.0220
189 STAPHYLOCOCCAL BACTERAEMIA 95 0.0218
190 TRANSPLANT REJECTION 175 0.0218
191 MATERNAL EXPOSURE TIMING UNSPECIFIED 82 0.0218
192 CREPITATIONS 64 0.0215
193 NORMAL NEWBORN 115 0.0211
194 JOINT STIFFNESS 554 0.0211
195 PLEURITIC PAIN 58 0.0210
196 DELIRIUM 728 0.0210
197 GRAFT VERSUS HOST DISEASE 150 0.0208
198 ORAL CANDIDIASIS 274 0.0208
199 THERAPEUTIC PRODUCT EFFECT DECREASED 930 0.0207
200 FEBRILE BONE MARROW APLASIA 88 0.0207
201 EPILEPSY 622 0.0203
202 CYTOMEGALOVIRUS COLITIS 46 0.0200
203 SINUS CONGESTION 268 0.0198
204 INFLAMMATION 1018 0.0197
205 KNEE ARTHROPLASTY 413 0.0196
206 UPPER RESPIRATORY TRACT INFECTION 903 0.0195
207 BLOOD IMMUNOGLOBULIN G DECREASED 48 0.0194
208 MOBILITY DECREASED 1386 0.0193
209 RHEUMATOID NODULE 53 0.0192
210 MUCORMYCOSIS 50 0.0192
211 PNEUMOCYSTIS JIROVECII PNEUMONIA 193 0.0192
212 INJURY 1344 0.0191
213 AFFECT LABILITY 182 0.0189
214 TENOSYNOVITIS 52 0.0188
215 DRUG-INDUCED LIVER INJURY 589 0.0188
216 AORTIC ARTERIOSCLEROSIS 48 0.0186
217 ADVERSE REACTION 246 0.0185
218 STOMATITIS 1106 0.0182
219 MOTOR DYSFUNCTION 185 0.0181
220 EPSTEIN-BARR VIRUS INFECTION 113 0.0181
221 INCREASED BRONCHIAL SECRETION 46 0.0180
222 ESCHERICHIA SEPSIS 52 0.0179
223 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 91 0.0179
224 KLEBSIELLA INFECTION 90 0.0178
225 JOINT SWELLING 2138 0.0177
226 OEDEMA 955 0.0176
227 VASCULITIS 205 0.0176
228 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 58 0.0175
229 THROMBOTIC MICROANGIOPATHY 171 0.0175
230 ILL-DEFINED DISORDER 1062 0.0175
231 ACUTE GRAFT VERSUS HOST DISEASE 80 0.0175
232 DISCOMFORT 1066 0.0175
233 RHINOVIRUS INFECTION 67 0.0172
234 MULTI-ORGAN FAILURE 297 0.0172
235 ELECTRIC SHOCK SENSATION 48 0.0171
236 HEMIPARESIS 289 0.0170
237 SWELLING 1594 0.0170
238 DRUG TOLERANCE 86 0.0170
239 MUSCULOSKELETAL PAIN 890 0.0170
240 DISSEMINATED INTRAVASCULAR COAGULATION 239 0.0170
241 BK VIRUS INFECTION 57 0.0169
242 VAGINAL DISCHARGE 170 0.0168
243 BLOOD CREATININE DECREASED 52 0.0166
244 VENOUS THROMBOSIS 65 0.0165
245 ADENOVIRUS INFECTION 48 0.0165
246 DISABILITY 327 0.0165
247 MUSCULOSKELETAL STIFFNESS 1437 0.0164
248 HYPERTHERMIA 124 0.0162
249 INCORRECT DRUG ADMINISTRATION RATE 69 0.0162
250 CYSTITIS HAEMORRHAGIC 65 0.0161
251 OESOPHAGEAL CANDIDIASIS 64 0.0160
252 HEPATITIS 410 0.0160
253 RALES 93 0.0160
254 PULMONARY ALVEOLAR HAEMORRHAGE 89 0.0159
255 EAR INFECTION 422 0.0158
256 EXPOSURE DURING PREGNANCY 985 0.0158
257 DRUG INTOLERANCE 1525 0.0158
258 MONOCYTE COUNT INCREASED 57 0.0157
259 MATERNAL EXPOSURE DURING PREGNANCY 1397 0.0157
260 HYPERURICAEMIA 64 0.0156
261 HYPOALBUMINAEMIA 121 0.0155
262 HYPOGAMMAGLOBULINAEMIA 101 0.0154
263 FREQUENT BOWEL MOVEMENTS 409 0.0151
264 TREATMENT FAILURE 1253 0.0151
265 OSTEOPOROSIS 621 0.0151
266 DYSAESTHESIA 46 0.0150
267 EAR PAIN 291 0.0150
268 ULCER HAEMORRHAGE 101 0.0149
269 NEUTROPHIL COUNT INCREASED 152 0.0148
270 GENERAL PHYSICAL HEALTH DETERIORATION 1715 0.0148
271 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 254 0.0148
272 ATELECTASIS 143 0.0148
273 TYPE I HYPERSENSITIVITY 52 0.0148
274 ANAPHYLACTIC SHOCK 375 0.0145
275 BACK DISORDER 236 0.0145
276 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 138 0.0144
277 OPTIC NEURITIS 130 0.0143
278 SINUSITIS 1458 0.0142
279 THROMBOTIC THROMBOCYTOPENIC PURPURA 50 0.0142
280 HYPERTENSION 2995 0.0141
281 BACTERIAL SEPSIS 46 0.0141
282 COORDINATION ABNORMAL 195 0.0140
283 ROAD TRAFFIC ACCIDENT 581 0.0139
284 PARAESTHESIA ORAL 200 0.0139
285 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 104 0.0138
286 ANTINUCLEAR ANTIBODY POSITIVE 45 0.0138
287 INFUSION SITE EXTRAVASATION 86 0.0138
288 JOINT EFFUSION 95 0.0138
289 BLOOD PRESSURE INCREASED 2092 0.0137
290 BODY TEMPERATURE INCREASED 279 0.0137
291 DRUG LEVEL BELOW THERAPEUTIC 75 0.0136
292 ACUTE RESPIRATORY DISTRESS SYNDROME 239 0.0135
293 HYPOAESTHESIA 2019 0.0135
294 COVID-19 PNEUMONIA 159 0.0135
295 BLOOD THYROID STIMULATING HORMONE DECREASED 61 0.0134
296 MUSCULAR WEAKNESS 1516 0.0133
297 RESPIRATORY TRACT CONGESTION 210 0.0132
298 IMMUNE THROMBOCYTOPENIA 60 0.0131
299 THROAT IRRITATION 586 0.0130
300 BRONCHOSPASM 186 0.0130
301 CHRONIC GRAFT VERSUS HOST DISEASE 47 0.0130
302 FLUID RETENTION 660 0.0130
303 SNEEZING 289 0.0129
304 DRY MOUTH 1045 0.0129
305 ACUTE PULMONARY OEDEMA 72 0.0128
306 PSEUDOMONAS INFECTION 110 0.0128
307 CLOSTRIDIUM DIFFICILE COLITIS 135 0.0127
308 TACHYPNOEA 173 0.0127
309 LIVER DISORDER 564 0.0127
310 PNEUMONIA FUNGAL 50 0.0127
311 LYMPHOPENIA 178 0.0126
312 SLEEP DISORDER 887 0.0126
313 HYPERSENSITIVITY 2330 0.0125
314 HEPATOCELLULAR INJURY 177 0.0125
315 ABDOMINAL ABSCESS 55 0.0124
316 DYSLIPIDAEMIA 63 0.0124
317 URTICARIA 2071 0.0123
318 VENOOCCLUSIVE LIVER DISEASE 61 0.0123
319 CYSTITIS 393 0.0123
320 RESPIRATORY DISORDER 369 0.0123
321 SINUS DISORDER 244 0.0123
322 GASTROINTESTINAL DISORDER 1102 0.0123
323 APLASTIC ANAEMIA 64 0.0122
324 NASOPHARYNGITIS 2257 0.0122
325 DERMATITIS EXFOLIATIVE 61 0.0122
326 ENTERITIS 78 0.0122
327 RASH ERYTHEMATOUS 581 0.0121
328 INTERSTITIAL LUNG DISEASE 587 0.0121
329 BACTERAEMIA 142 0.0120
330 SEPTIC SHOCK 520 0.0119
331 ANAPHYLACTOID REACTION 49 0.0119
332 DYSPEPSIA 1171 0.0119
333 WEIGHT FLUCTUATION 124 0.0118
334 VEIN DISORDER 59 0.0118
335 CYTOMEGALOVIRUS INFECTION REACTIVATION 52 0.0118
336 MACULAR DEGENERATION 140 0.0117
337 DEMYELINATION 48 0.0117
338 MYOPATHY 101 0.0117
339 BLOOD ALBUMIN DECREASED 92 0.0116
340 IRON DEFICIENCY 52 0.0116
341 HEART RATE INCREASED 1138 0.0115
342 SKIN HAEMORRHAGE 170 0.0115
343 DYSPHORIA 58 0.0114
344 PNEUMONIA BACTERIAL 105 0.0114
345 SKIN LACERATION 124 0.0114
346 MIGRAINE 1085 0.0114
347 SARS-COV-2 TEST POSITIVE 150 0.0113
348 IMMUNOSUPPRESSION 100 0.0113
349 ACUTE RESPIRATORY FAILURE 218 0.0113
350 INFLAMMATORY MARKER INCREASED 56 0.0113
351 SYNOVIAL CYST 52 0.0113
352 HERPES SIMPLEX 73 0.0112
353 ASTHMA 1258 0.0111
354 MULTIPLE ORGAN DYSFUNCTION SYNDROME 315 0.0111
355 PYREXIA 3843 0.0111
356 MULTIPLE SCLEROSIS RELAPSE 761 0.0111
357 INTESTINAL ISCHAEMIA 61 0.0111
358 EOSINOPHIL COUNT INCREASED 92 0.0110
359 CHEST DISCOMFORT 1127 0.0110
360 PULMONARY HAEMORRHAGE 86 0.0110
361 PURPURA 97 0.0110
362 GASTROOESOPHAGEAL REFLUX DISEASE 880 0.0109
363 INFECTION 1581 0.0109
364 SHOCK HAEMORRHAGIC 88 0.0108
365 WEIGHT INCREASED 2418 0.0108
366 RASH MACULO-PAPULAR 240 0.0108
367 COLITIS ULCERATIVE 482 0.0108
368 CANDIDA INFECTION 182 0.0108
369 BREATH SOUNDS ABNORMAL 53 0.0107
370 PHLEBITIS 55 0.0107
371 RHINITIS 86 0.0107
372 WHITE BLOOD CELL COUNT INCREASED 409 0.0106
373 ABDOMINAL DISCOMFORT 1784 0.0106
374 COLITIS 403 0.0106
375 VAGINAL INFECTION 50 0.0106
376 HYPERGLYCAEMIA 387 0.0106
377 RENAL TUBULAR NECROSIS 104 0.0106
378 NECROSIS 59 0.0106
379 CYTOKINE RELEASE SYNDROME 211 0.0105
380 HAEMATOCRIT DECREASED 208 0.0105
381 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 745 0.0105
382 TUMOUR LYSIS SYNDROME 92 0.0104
383 CYANOSIS 164 0.0104
384 MYASTHENIA GRAVIS 83 0.0103
385 PERIPHERAL SWELLING 1575 0.0102
386 APHTHOUS ULCER 79 0.0102
387 BLOOD URINE PRESENT 193 0.0102
388 CONTUSION 978 0.0101
389 THERAPY NON-RESPONDER 455 0.0101
390 BLOOD LACTATE DEHYDROGENASE INCREASED 160 0.0101
391 CONFUSIONAL STATE 1629 0.0101
392 TACHYCARDIA 893 0.0100
393 ORAL HERPES 196 0.0100
394 FEELING HOT 615 0.0100
395 GENERALISED ERYTHEMA 57 0.0100
396 OROPHARYNGEAL DISCOMFORT 90 0.0100
397 EATING DISORDER 211 0.0099
398 HYPOKALAEMIA 457 0.0099
399 DRUG SPECIFIC ANTIBODY PRESENT 64 0.0098
400 ARTHRITIS 774 0.0098
401 HAEMOLYTIC ANAEMIA 88 0.0098
402 TOXIC EPIDERMAL NECROLYSIS 149 0.0098
403 RECTAL HAEMORRHAGE 421 0.0098
404 EYE INFLAMMATION 93 0.0097
405 HYPOPHOSPHATAEMIA 72 0.0097
406 LUNG INFILTRATION 86 0.0097
407 HEPATIC FUNCTION ABNORMAL 362 0.0097
408 PYELONEPHRITIS 84 0.0097
409 ENCEPHALITIS 67 0.0097
410 BRONCHITIS 715 0.0096
411 OSTEONECROSIS 317 0.0096
412 NECK PAIN 539 0.0096
413 BACTERIAL INFECTION 179 0.0096
414 THROMBOCYTOPENIA 1065 0.0095
415 RESPIRATORY DISTRESS 262 0.0095
416 ANGINA PECTORIS 272 0.0095
417 AUTOIMMUNE HEPATITIS 66 0.0095
418 HYPERVENTILATION 55 0.0095
419 AMNESIA 617 0.0095
420 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 518 0.0094
421 ANAPHYLACTIC REACTION 521 0.0094
422 TOOTH ABSCESS 96 0.0094
423 FLANK PAIN 88 0.0094
424 HEART RATE IRREGULAR 212 0.0094
425 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 77 0.0093
426 RESPIRATORY FAILURE 680 0.0093
427 OFF LABEL USE 8135 0.0093
428 SHOCK 212 0.0092
429 HYDRONEPHROSIS 69 0.0092
430 GENERALISED OEDEMA 114 0.0092
431 HAEMOLYSIS 71 0.0092
432 ADRENAL INSUFFICIENCY 111 0.0091
433 CONDITION AGGRAVATED 2765 0.0091
434 PNEUMONIA 2944 0.0091
435 GAMMA-GLUTAMYLTRANSFERASE INCREASED 201 0.0091
436 ANURIA 78 0.0091
437 HYPOXIA 318 0.0090
438 OLIGURIA 56 0.0090
439 TYPE 1 DIABETES MELLITUS 54 0.0090
440 MULTIPLE SCLEROSIS 423 0.0088
441 PERONEAL NERVE PALSY 50 0.0088
442 SINUS BRADYCARDIA 85 0.0088
443 PETECHIAE 91 0.0087
444 SERUM FERRITIN INCREASED 46 0.0087
445 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 148 0.0087
446 HAEMODYNAMIC INSTABILITY 66 0.0087
447 NODULE 113 0.0086
448 MEMORY IMPAIRMENT 1187 0.0086
449 TENDERNESS 90 0.0086
450 RHINORRHOEA 558 0.0086
451 ESCHERICHIA INFECTION 71 0.0086
452 PHARYNGITIS 107 0.0086
453 NEURALGIA 209 0.0086
454 PARAESTHESIA 1350 0.0086
455 ANAL FISSURE 46 0.0086
456 ULCER 136 0.0085
457 APHASIA 258 0.0085
458 SPUTUM DISCOLOURED 81 0.0085
459 HEPATITIS CHOLESTATIC 51 0.0085
460 LEUKOPENIA 421 0.0084
461 FLUSHING 854 0.0084
462 HYPOTHERMIA 85 0.0084
463 BRAIN OEDEMA 106 0.0084
464 FAECES SOFT 61 0.0084
465 PHARYNGEAL SWELLING 82 0.0084
466 AGRANULOCYTOSIS 155 0.0083
467 SEASONAL ALLERGY 118 0.0083
468 THROAT TIGHTNESS 224 0.0083
469 SEPSIS 917 0.0082
470 PERIPHERAL SENSORY NEUROPATHY 48 0.0082
471 PULMONARY TOXICITY 58 0.0082
472 ERYTHEMA 1674 0.0081
473 FEBRILE NEUTROPENIA 540 0.0081
474 UPPER-AIRWAY COUGH SYNDROME 67 0.0081
475 GLUCOSE TOLERANCE IMPAIRED 48 0.0081
476 HAEMATOCHEZIA 447 0.0081
477 DYSARTHRIA 304 0.0081
478 CLOSTRIDIUM DIFFICILE INFECTION 176 0.0081
479 DECREASED IMMUNE RESPONSIVENESS 79 0.0080
480 TOOTH INFECTION 106 0.0080
481 BLOOD BILIRUBIN INCREASED 215 0.0080
482 LEUKOCYTOSIS 144 0.0079
483 LARYNGEAL OEDEMA 49 0.0079
484 FACE OEDEMA 134 0.0079
485 MENINGITIS 53 0.0079
486 PRODUCT USE ISSUE 1491 0.0079
487 PLEURISY 47 0.0079
488 CATARACT 468 0.0079
489 NEUTROPHIL COUNT DECREASED 320 0.0078
490 HEPATITIS ACUTE 51 0.0078
491 INTESTINAL PERFORATION 88 0.0078
492 CHEST PAIN 1450 0.0078
493 BLOOD UREA INCREASED 131 0.0078
494 CHILLS 917 0.0078
495 CHOLESTASIS 150 0.0078
496 OEDEMA PERIPHERAL 949 0.0078
497 ALANINE AMINOTRANSFERASE INCREASED 478 0.0078
498 ABSCESS 124 0.0078
499 DERMATITIS BULLOUS 56 0.0077
500 HEPATOMEGALY 76 0.0077
501 CENTRAL NERVOUS SYSTEM LESION 106 0.0077
502 CONJUNCTIVITIS 143 0.0077
503 SINUS TACHYCARDIA 109 0.0077
504 HYPERAESTHESIA 63 0.0077
505 BRADYCARDIA 405 0.0076
506 LARGE INTESTINE PERFORATION 53 0.0076
507 HAEMODIALYSIS 64 0.0076
508 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 364 0.0076
509 DRY THROAT 77 0.0076
510 INTERVERTEBRAL DISC DEGENERATION 70 0.0076
511 TEMPERATURE INTOLERANCE 78 0.0076
512 OBSTRUCTIVE AIRWAYS DISORDER 84 0.0075
513 INJECTION SITE EXTRAVASATION 93 0.0075
514 ASPARTATE AMINOTRANSFERASE INCREASED 400 0.0075
515 HEPATIC CYTOLYSIS 96 0.0075
516 BLOOD PRESSURE DECREASED 500 0.0075
517 ALOPECIA 1473 0.0075
518 CARDIOMEGALY 92 0.0075
519 RASH 3258 0.0075
520 NASAL CONGESTION 438 0.0074
521 PLATELET COUNT INCREASED 97 0.0074
522 ABDOMINAL PAIN 1727 0.0074
523 VIRAL INFECTION 247 0.0074
524 FUNGAL INFECTION 247 0.0074
525 ARTHRALGIA 3078 0.0074
526 UTERINE LEIOMYOMA 54 0.0074
527 SPINAL OSTEOARTHRITIS 64 0.0073
528 BONE MARROW FAILURE 148 0.0073
529 PARALYSIS 104 0.0073
530 ACUTE CORONARY SYNDROME 60 0.0072
531 OROPHARYNGEAL PAIN 670 0.0072
532 ENCEPHALOPATHY 177 0.0072
533 PANCYTOPENIA 402 0.0072
534 PREGNANCY 143 0.0071
535 DIFFUSE LARGE B-CELL LYMPHOMA 55 0.0071
536 RED BLOOD CELL COUNT DECREASED 204 0.0071
537 HERPES ZOSTER 409 0.0071
538 RENAL CYST 56 0.0070
539 DECREASED APPETITE 1628 0.0070
540 PNEUMOTHORAX 111 0.0070
541 WEIGHT DECREASED 1953 0.0070
542 HYPERHIDROSIS 899 0.0070
543 URINE OUTPUT DECREASED 61 0.0070
544 DRUG LEVEL DECREASED 71 0.0070
545 WHITE BLOOD CELL COUNT DECREASED 756 0.0070
546 EYELID OEDEMA 81 0.0070
547 BLOOD MAGNESIUM DECREASED 60 0.0069
548 EMPHYSEMA 70 0.0069
549 KIDNEY INFECTION 135 0.0069
550 ABDOMINAL PAIN UPPER 1415 0.0069
551 ATRIOVENTRICULAR BLOCK COMPLETE 46 0.0069
552 MUSCLE SPASMS 1259 0.0069
553 NEPHROTIC SYNDROME 47 0.0068
554 GASTROENTERITIS 100 0.0068
555 BLOOD CREATININE INCREASED 446 0.0068
556 POOR QUALITY SLEEP 145 0.0067
557 BLOOD ALKALINE PHOSPHATASE INCREASED 167 0.0067
558 PAIN 4119 0.0067
559 INFUSION SITE PAIN 86 0.0067
560 SMALL INTESTINAL OBSTRUCTION 82 0.0067
561 DIPLOPIA 173 0.0067
562 PNEUMONITIS 181 0.0066
563 HEADACHE 4161 0.0066
564 DEVICE RELATED INFECTION 102 0.0066
565 PSORIASIS 865 0.0066
566 DENTAL CARIES 73 0.0066
567 VISUAL IMPAIRMENT 816 0.0066
568 HICCUPS 54 0.0066
569 LIGAMENT SPRAIN 65 0.0066
570 DYSPNOEA 3716 0.0066
571 MOUTH ULCERATION 138 0.0065
572 DEPRESSION 1490 0.0065
573 HYPOMAGNESAEMIA 91 0.0065
574 GINGIVAL PAIN 52 0.0065
575 PALPITATIONS 765 0.0065
576 DYSPHAGIA 620 0.0065
577 RENAL FAILURE ACUTE 277 0.0065
578 COUGH 1830 0.0065
579 PLEURAL EFFUSION 397 0.0065
580 TRANSAMINASES INCREASED 145 0.0065
581 GAIT DISTURBANCE 1247 0.0065
582 PULMONARY MASS 97 0.0065
583 IRON DEFICIENCY ANAEMIA 60 0.0065
584 ASCITES 191 0.0065
585 PRODUCTIVE COUGH 310 0.0065
586 STAPHYLOCOCCAL INFECTION 214 0.0065
587 HAEMOGLOBIN DECREASED 666 0.0065
588 ABDOMINAL DISTENSION 677 0.0065
589 HYPOTENSION 1300 0.0065
590 DIABETES MELLITUS 493 0.0065
591 PAIN IN EXTREMITY 1900 0.0064
592 BLADDER DISORDER 64 0.0064
593 NEPHROPATHY 60 0.0064
594 SKIN ULCER 166 0.0064
595 BLOOD IRON DECREASED 76 0.0064
596 ATRIAL FLUTTER 51 0.0064
597 DECUBITUS ULCER 52 0.0064
598 HYPERBILIRUBINAEMIA 66 0.0064
599 ASTHENIA 2389 0.0063
600 MALNUTRITION 71 0.0063
601 HEPATIC FAILURE 191 0.0063
602 PLATELET COUNT DECREASED 675 0.0063
603 PALLOR 172 0.0063
604 BLOOD THYROID STIMULATING HORMONE INCREASED 58 0.0063
605 ACUTE HEPATIC FAILURE 86 0.0063
606 HYPOCALCAEMIA 119 0.0063
607 LIPASE INCREASED 48 0.0063
608 PRODUCT USE IN UNAPPROVED INDICATION 1551 0.0063
609 ERYTHEMA MULTIFORME 58 0.0062
610 ADVERSE EVENT 572 0.0062
611 PROTEINURIA 118 0.0062
612 RENAL IMPAIRMENT 521 0.0062
613 GASTRITIS 163 0.0062
614 SPINAL COMPRESSION FRACTURE 51 0.0062
615 MALAISE 2703 0.0062
616 TOXIC SKIN ERUPTION 62 0.0061
617 VOMITING 2894 0.0061
618 FEELING COLD 171 0.0061
619 PANCREATITIS ACUTE 138 0.0061
620 EAR DISCOMFORT 63 0.0061
621 VENTRICULAR TACHYCARDIA 101 0.0061
622 EOSINOPHILIA 107 0.0061
623 DIARRHOEA HAEMORRHAGIC 57 0.0061
624 MITRAL VALVE INCOMPETENCE 69 0.0061
625 COAGULOPATHY 101 0.0061
626 LYMPHADENOPATHY 214 0.0060
627 PERIPHERAL COLDNESS 83 0.0060
628 CYTOPENIA 74 0.0060
629 PRURITUS 2314 0.0060
630 SPINAL DISORDER 57 0.0060
631 URINARY TRACT INFECTION 1025 0.0060
632 HEPATIC ENCEPHALOPATHY 56 0.0060
633 INFLUENZA 664 0.0059
634 FACIAL PAIN 53 0.0059
635 EYE INFECTION 67 0.0059
636 CELLULITIS 299 0.0059
637 TRICUSPID VALVE INCOMPETENCE 47 0.0059
638 FEAR 159 0.0059
639 URINARY INCONTINENCE 175 0.0059
640 TOOTH FRACTURE 65 0.0059
641 SKIN REACTION 83 0.0059
642 ANAEMIA 1121 0.0059
643 MELAENA 128 0.0058
644 MASS 81 0.0058
645 UNDERDOSE 423 0.0058
646 SKIN INFECTION 65 0.0058
647 PSYCHOTIC DISORDER 171 0.0058
648 LOCALISED INFECTION 140 0.0058
649 BLOOD CREATINE PHOSPHOKINASE INCREASED 166 0.0058
650 PULMONARY CONGESTION 76 0.0058
651 PULMONARY OEDEMA 258 0.0058
652 LUNG INFECTION 89 0.0057
653 ALTERED STATE OF CONSCIOUSNESS 124 0.0057
654 MICTURITION URGENCY 65 0.0057
655 BLOOD PRESSURE ABNORMAL 113 0.0057
656 ANAL INCONTINENCE 51 0.0057
657 ANXIETY 1604 0.0056
658 LIMB DISCOMFORT 174 0.0056
659 UVEITIS 76 0.0056
660 BLOOD CALCIUM DECREASED 63 0.0056
661 FATIGUE 4349 0.0056
662 MYOCARDITIS 64 0.0056
663 TOOTH DISORDER 124 0.0056
664 RESPIRATORY TRACT INFECTION 145 0.0056
665 CYST 69 0.0056
666 INCREASED TENDENCY TO BRUISE 51 0.0055
667 DIABETES MELLITUS INADEQUATE CONTROL 98 0.0055
668 BLOOD POTASSIUM DECREASED 166 0.0055
669 GOUT 99 0.0055
670 PERITONITIS 114 0.0055
671 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 287 0.0055
672 RESTLESS LEGS SYNDROME 100 0.0055
673 POLYURIA 45 0.0055
674 MUSCULOSKELETAL CHEST PAIN 85 0.0055
675 INSOMNIA 1450 0.0054
676 PROCEDURAL PAIN 151 0.0054
677 STEVENS-JOHNSON SYNDROME 121 0.0054
678 HYPERLIPIDAEMIA 65 0.0054
679 CARDIOGENIC SHOCK 78 0.0054
680 CARDIOMYOPATHY 80 0.0054
681 ADVERSE DRUG REACTION 485 0.0054
682 INJECTION SITE REACTION 371 0.0054
683 INFLUENZA LIKE ILLNESS 442 0.0054
684 DYSPNOEA EXERTIONAL 200 0.0053
685 BACK PAIN 1233 0.0053
686 HAEMOPTYSIS 147 0.0053
687 UPPER GASTROINTESTINAL HAEMORRHAGE 88 0.0052
688 COLD SWEAT 92 0.0052
689 THERAPEUTIC RESPONSE DECREASED 316 0.0052
690 COVID-19 913 0.0052
691 MUCOSAL INFLAMMATION 136 0.0052
692 ANHEDONIA 136 0.0052
693 JAUNDICE 139 0.0052
694 APPENDICITIS 48 0.0051
695 STATUS EPILEPTICUS 58 0.0051
696 DEFORMITY 48 0.0051
697 GASTROINTESTINAL INFECTION 46 0.0051
698 VITAMIN D DEFICIENCY 50 0.0051
699 HYPOKINESIA 74 0.0051
700 UROSEPSIS 47 0.0051
701 SKIN LESION 139 0.0051
702 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 52 0.0051
703 PANCREATITIS 266 0.0050
704 APHONIA 70 0.0050
705 DERMATITIS ALLERGIC 63 0.0050
706 SCAB 57 0.0050
707 HEPATIC STEATOSIS 93 0.0050
708 RENAL FAILURE 661 0.0050
709 THERAPEUTIC RESPONSE SHORTENED 165 0.0050
710 GLOMERULAR FILTRATION RATE DECREASED 61 0.0050
711 RIB FRACTURE 102 0.0050
712 VENTRICULAR FIBRILLATION 55 0.0049
713 TENDON RUPTURE 61 0.0049
714 ATRIAL FIBRILLATION 481 0.0049
715 NAUSEA 3908 0.0049
716 HYPONATRAEMIA 277 0.0049
717 OVARIAN CYST 49 0.0049
718 FISTULA 55 0.0049
719 ATAXIA 58 0.0049
720 MUSCLE TIGHTNESS 79 0.0049
721 DRUG ERUPTION 86 0.0048
722 HYPOAESTHESIA ORAL 73 0.0048
723 FEELING JITTERY 92 0.0048
724 HYPERKALAEMIA 169 0.0048
725 GALLBLADDER DISORDER 86 0.0048
726 RASH PRURITIC 260 0.0048
727 HAEMATURIA 164 0.0048
728 CEREBRAL INFARCTION 117 0.0048
729 SLEEP APNOEA SYNDROME 91 0.0048
730 DIARRHOEA 3046 0.0047
731 RENAL INJURY 139 0.0047
732 GASTROINTESTINAL HAEMORRHAGE 391 0.0047
733 CONSTIPATION 1013 0.0046
734 PERICARDIAL EFFUSION 107 0.0046
735 RENAL PAIN 49 0.0046
736 VENTRICULAR EXTRASYSTOLES 48 0.0046
737 SENSORY DISTURBANCE 74 0.0046
738 DIZZINESS 2293 0.0046
739 SWELLING FACE 299 0.0046
740 RESTLESSNESS 167 0.0046
741 DRUG RESISTANCE 116 0.0045
742 RETCHING 96 0.0045
743 PHOTOPHOBIA 84 0.0045
744 GASTROINTESTINAL PAIN 49 0.0044
745 EJECTION FRACTION DECREASED 69 0.0044
746 SPLENOMEGALY 52 0.0044
747 MANIA 73 0.0044
748 LIMB INJURY 120 0.0044
749 OSTEOPENIA 67 0.0044
750 PULMONARY EMBOLISM 419 0.0044
751 HIATUS HERNIA 57 0.0044
752 MYOCARDIAL ISCHAEMIA 50 0.0044
753 INTERNATIONAL NORMALISED RATIO INCREASED 125 0.0044
754 ASPIRATION 48 0.0044
755 CARDIO-RESPIRATORY ARREST 183 0.0044
756 FALL 1456 0.0044
757 NEUTROPENIA 594 0.0044
758 DIVERTICULITIS 121 0.0044
759 PULMONARY THROMBOSIS 47 0.0043
760 AGITATION 316 0.0043
761 PSYCHOMOTOR HYPERACTIVITY 71 0.0043
762 INTENTIONAL PRODUCT MISUSE 374 0.0043
763 GASTROENTERITIS VIRAL 77 0.0043
764 TOOTHACHE 77 0.0042
765 DYSURIA 156 0.0042
766 LABORATORY TEST ABNORMAL 125 0.0042
767 CARDIAC FAILURE 340 0.0042
768 CIRCULATORY COLLAPSE 72 0.0042
769 ELECTROLYTE IMBALANCE 49 0.0042
770 CARPAL TUNNEL SYNDROME 59 0.0042
771 BLOOD TEST ABNORMAL 59 0.0042
772 BLOOD SODIUM DECREASED 79 0.0042
773 BALANCE DISORDER 361 0.0042
774 PRESYNCOPE 101 0.0041
775 MYELODYSPLASTIC SYNDROME 60 0.0041
776 MENTAL STATUS CHANGES 115 0.0041
777 MEDICATION ERROR 230 0.0041
778 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 121 0.0041
779 HYPERCALCAEMIA 51 0.0041
780 MUSCULOSKELETAL DISCOMFORT 71 0.0041
781 DEEP VEIN THROMBOSIS 266 0.0041
782 CHOLELITHIASIS 134 0.0041
783 CARDIAC ARREST 337 0.0041
784 INTERVERTEBRAL DISC PROTRUSION 89 0.0041
785 GASTRIC ULCER 77 0.0040
786 MENTAL DISORDER 176 0.0040
787 PNEUMONIA ASPIRATION 101 0.0040
788 CHOLECYSTITIS 48 0.0040
789 SECRETION DISCHARGE 50 0.0040
790 SKIN FISSURES 78 0.0040
791 DRY EYE 199 0.0040
792 DYSPHONIA 232 0.0040
793 PHARYNGEAL OEDEMA 61 0.0040
794 FOOT FRACTURE 75 0.0040
795 ANGIOEDEMA 175 0.0040
796 ACUTE KIDNEY INJURY 605 0.0039
797 BONE DISORDER 72 0.0039
798 IMMUNE SYSTEM DISORDER 52 0.0039
799 PHOTOSENSITIVITY REACTION 65 0.0039
800 HOT FLUSH 296 0.0039
801 HYPOTHYROIDISM 125 0.0039
802 ARRHYTHMIA 184 0.0039
803 GINGIVAL BLEEDING 53 0.0039
804 ABDOMINAL PAIN LOWER 98 0.0039
805 DRUG LEVEL INCREASED 64 0.0039
806 OSTEOMYELITIS 70 0.0039
807 PRODUCT QUALITY ISSUE 524 0.0039
808 CEREBRAL HAEMORRHAGE 138 0.0039
809 METABOLIC ACIDOSIS 123 0.0038
810 SPEECH DISORDER 201 0.0038
811 BLOOD POTASSIUM INCREASED 62 0.0038
812 LOSS OF CONSCIOUSNESS 486 0.0038
813 TUBULOINTERSTITIAL NEPHRITIS 71 0.0038
814 ECONOMIC PROBLEM 57 0.0038
815 TREMOR 621 0.0037
816 ACUTE MYELOID LEUKAEMIA 58 0.0037
817 BURNING SENSATION 258 0.0037
818 DIALYSIS 52 0.0037
819 RASH PAPULAR 82 0.0037
820 DISEASE RECURRENCE 174 0.0037
821 PULMONARY HYPERTENSION 76 0.0036
822 SWOLLEN TONGUE 113 0.0036
823 DEPRESSED LEVEL OF CONSCIOUSNESS 143 0.0036
824 MOVEMENT DISORDER 116 0.0036
825 INCORRECT PRODUCT ADMINISTRATION DURATION 78 0.0036
826 NEPHROLITHIASIS 165 0.0036
827 COGNITIVE DISORDER 167 0.0036
828 EYE SWELLING 132 0.0035
829 EPISTAXIS 265 0.0035
830 GLAUCOMA 68 0.0035
831 ORAL PAIN 79 0.0035
832 METASTASES TO LIVER 62 0.0035
833 DEHYDRATION 470 0.0035
834 INTRAOCULAR PRESSURE INCREASED 45 0.0035
835 GENERALISED TONIC-CLONIC SEIZURE 58 0.0035
836 COLON CANCER 52 0.0035
837 DISEASE PROGRESSION 410 0.0035
838 FOETAL EXPOSURE DURING PREGNANCY 281 0.0035
839 HYPERSOMNIA 99 0.0034
840 EYE DISORDER 113 0.0034
841 FLUID OVERLOAD 50 0.0034
842 HAEMORRHOIDS 67 0.0034
843 LIP SWELLING 114 0.0034
844 MUSCULOSKELETAL DISORDER 65 0.0034
845 DRUG INEFFECTIVE 4495 0.0034
846 DYSMENORRHOEA 45 0.0034
847 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 611 0.0034
848 SCAR 58 0.0034
849 URINARY RETENTION 113 0.0034
850 COMA 161 0.0034
851 BLOOD GLUCOSE INCREASED 636 0.0034
852 ISCHAEMIC STROKE 60 0.0034
853 ANKLE FRACTURE 52 0.0034
854 TINNITUS 154 0.0033
855 BLINDNESS UNILATERAL 47 0.0033
856 SKIN DISORDER 111 0.0033
857 LYMPHOMA 51 0.0033
858 INTENTIONAL DOSE OMISSION 94 0.0033
859 PRURITUS GENERALISED 71 0.0033
860 UNEVALUABLE EVENT 248 0.0033
861 JOINT INJURY 70 0.0033
862 DEVICE OCCLUSION 46 0.0033
863 VERTIGO 199 0.0033
864 PAIN IN JAW 91 0.0032
865 SKIN EXFOLIATION 271 0.0032
866 CONVULSION 183 0.0032
867 MYELOSUPPRESSION 115 0.0032
868 PREMATURE BABY 96 0.0032
869 GASTRIC DISORDER 109 0.0032
870 CORONARY ARTERY DISEASE 96 0.0032
871 UPPER LIMB FRACTURE 63 0.0032
872 HAEMATEMESIS 80 0.0032
873 LACTIC ACIDOSIS 102 0.0031
874 SPINAL FRACTURE 63 0.0031
875 THERAPY PARTIAL RESPONDER 49 0.0031
876 INSURANCE ISSUE 48 0.0031
877 ECZEMA 164 0.0031
878 METASTASES TO BONE 51 0.0031
879 MIDDLE INSOMNIA 58 0.0031
880 MYALGIA 528 0.0031
881 HEPATOTOXICITY 69 0.0031
882 DEAFNESS 80 0.0031
883 FEEDING DISORDER 62 0.0031
884 HEAD INJURY 96 0.0030
885 OVERDOSE 648 0.0030
886 SKIN DISCOLOURATION 138 0.0030
887 SOMNOLENCE 603 0.0030
888 POLLAKIURIA 123 0.0029
889 ILLNESS 303 0.0029
890 EYE PAIN 164 0.0029
891 BASAL CELL CARCINOMA 45 0.0029
892 RENAL DISORDER 132 0.0028
893 BLOOD TRIGLYCERIDES INCREASED 50 0.0028
894 INCREASED APPETITE 54 0.0028
895 HAEMATOMA 73 0.0028
896 RASH GENERALISED 72 0.0028
897 BONE PAIN 162 0.0028
898 POST PROCEDURAL COMPLICATION 53 0.0028
899 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 71 0.0028
900 INTESTINAL OBSTRUCTION 104 0.0028
901 RESPIRATORY ARREST 76 0.0028
902 ACUTE MYOCARDIAL INFARCTION 81 0.0027
903 RASH MACULAR 96 0.0027
904 VISION BLURRED 375 0.0027
905 BLINDNESS 111 0.0027
906 LIVER FUNCTION TEST ABNORMAL 79 0.0027
907 DRUG INTERACTION 424 0.0027
908 OCULAR HYPERAEMIA 126 0.0027
909 HEAD DISCOMFORT 47 0.0027
910 LACRIMATION INCREASED 80 0.0026
911 DYSSTASIA 77 0.0026
912 DISTURBANCE IN ATTENTION 141 0.0026
913 HIP FRACTURE 84 0.0026
914 DISORIENTATION 102 0.0026
915 THROMBOSIS 207 0.0026
916 SEIZURE 296 0.0026
917 CARDIAC FAILURE CONGESTIVE 205 0.0025
918 BLOOD GLUCOSE ABNORMAL 47 0.0025
919 ABASIA 62 0.0025
920 CEREBROVASCULAR ACCIDENT 424 0.0025
921 PANIC ATTACK 91 0.0025
922 CHROMATURIA 56 0.0025
923 SYNCOPE 248 0.0025
924 HALLUCINATION 186 0.0025
925 VISUAL ACUITY REDUCED 81 0.0024
926 MUSCLE TWITCHING 56 0.0024
927 DIABETIC KETOACIDOSIS 58 0.0024
928 DYSGEUSIA 179 0.0024
929 CHOKING 47 0.0024
930 RHABDOMYOLYSIS 100 0.0024
931 FEMUR FRACTURE 74 0.0024
932 IMPAIRED WORK ABILITY 51 0.0024
933 NEUROPATHY PERIPHERAL 225 0.0024
934 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 55 0.0024
935 NERVOUSNESS 122 0.0023
936 HALLUCINATION, VISUAL 49 0.0023
937 ABNORMAL BEHAVIOUR 90 0.0023
938 ELECTROCARDIOGRAM QT PROLONGED 81 0.0022
939 MOOD SWINGS 71 0.0022
940 FEELING ABNORMAL 532 0.0022
941 NERVOUS SYSTEM DISORDER 69 0.0022
942 ACNE 167 0.0022
943 NEOPLASM PROGRESSION 76 0.0022
944 TREATMENT NONCOMPLIANCE 117 0.0021
945 FLATULENCE 121 0.0021
946 LETHARGY 122 0.0021
947 CARDIAC DISORDER 198 0.0021
948 EMOTIONAL DISORDER 65 0.0021
949 CRYING 76 0.0021
950 UNRESPONSIVE TO STIMULI 53 0.0021
951 HAEMORRHAGE 214 0.0020
952 PRODUCT PRESCRIBING ERROR 48 0.0020
953 DEPRESSED MOOD 105 0.0020
954 BONE DENSITY DECREASED 62 0.0020
955 MALIGNANT NEOPLASM PROGRESSION 202 0.0020
956 EYE PRURITUS 65 0.0019
957 EMOTIONAL DISTRESS 233 0.0019
958 LUNG NEOPLASM MALIGNANT 79 0.0019
959 OSTEONECROSIS OF JAW 47 0.0019
960 IRRITABILITY 114 0.0019
961 MYOCARDIAL INFARCTION 317 0.0018
962 HYPOACUSIS 78 0.0018
963 TRANSIENT ISCHAEMIC ATTACK 61 0.0018
964 NEOPLASM MALIGNANT 118 0.0018
965 HYPOPHAGIA 45 0.0018
966 HOSPITALISATION 269 0.0017
967 DRUG EXPOSURE DURING PREGNANCY 59 0.0017
968 ANGER 58 0.0017
969 DEMENTIA 45 0.0016
970 EYE IRRITATION 89 0.0015
971 DYSKINESIA 62 0.0015
972 AGGRESSION 75 0.0015
973 HYPOGLYCAEMIA 71 0.0015
974 DEATH 1214 0.0014
975 DRY SKIN 180 0.0013
976 THERAPEUTIC RESPONSE UNEXPECTED 59 0.0013
977 NO ADVERSE EVENT 236 0.0013
978 ACCIDENTAL OVERDOSE 46 0.0013
979 DRUG EFFECT DECREASED 62 0.0011
980 THERAPY CESSATION 53 0.0010
981 SURGERY 59 0.0010
982 SKIN IRRITATION 46 0.0010
983 SUICIDAL IDEATION 85 0.0009
984 PRODUCT DOSE OMISSION ISSUE 270 0.0009
985 INCORRECT DOSE ADMINISTERED 209 0.0009
986 CHRONIC KIDNEY DISEASE 69 0.0009
987 TOXICITY TO VARIOUS AGENTS 153 0.0009
988 SKIN BURNING SENSATION 62 0.0009
989 INJECTION SITE ERYTHEMA 75 0.0006
990 INJECTION SITE PAIN 174 0.0006
991 BREAST CANCER 46 0.0005
992 DRUG DEPENDENCE 69 0.0004
993 DRUG DOSE OMISSION 60 0.0004